These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25449959)

  • 1. Towards broadly protective polyvalent vaccines against hand, foot and mouth disease.
    Liu Q; Tong X; Huang Z
    Microbes Infect; 2015 Feb; 17(2):155-62. PubMed ID: 25449959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
    Klein MH
    Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.
    Liu CC; Chow YH; Chong P; Klein M
    Vaccine; 2014 Oct; 32(47):6177-82. PubMed ID: 25218294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of enterovirus 71 vaccines.
    Chong P; Liu CC; Chow YH; Chou AH; Klein M
    Clin Infect Dis; 2015 Mar; 60(5):797-803. PubMed ID: 25352588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
    Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
    Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of research and development of vaccines for enterovirus 71.
    Reed Z; Cardosa MJ
    Vaccine; 2016 Jun; 34(26):2967-2970. PubMed ID: 26973065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
    Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
    Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EV71: an emerging infectious disease vaccine target in the Far East?
    Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
    Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease.
    Liu D; Leung K; Jit M; Yu H; Yang J; Liao Q; Liu F; Zheng Y; Wu JT
    Clin Microbiol Infect; 2020 Mar; 26(3):373-380. PubMed ID: 31279839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.
    Zhou Y; Li JX; Jin PF; Wang YX; Zhu FC
    Expert Rev Vaccines; 2016 Jul; 15(7):803-13. PubMed ID: 27206811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014-2016, prior to the introduction of the enterovirus 71 vaccine.
    Li J; Pan H; Wang X; Zhu Q; Ge Y; Cai J; Li Y; Xia A; Hu J; Zeng M
    Emerg Microbes Infect; 2018 Mar; 7(1):37. PubMed ID: 29559626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).
    Mao QY; Wang Y; Bian L; Xu M; Liang Z
    Expert Rev Vaccines; 2016 May; 15(5):599-606. PubMed ID: 26732723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
    Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.